JP2003533167A5 - - Google Patents

Info

Publication number

JP2003533167A5

JP2003533167A5 JP2000583963A JP2000583963A JP2003533167A5 JP 2003533167 A5 JP2003533167 A5 JP 2003533167A5 JP 2000583963 A JP2000583963 A JP 2000583963A JP 2000583963 A JP2000583963 A JP 2000583963A JP 2003533167 A5 JP2003533167 A5 JP 2003533167A5

Authority

JP

Japan

Prior art keywords

desamino

peptide

ser

composition

hpth

Prior art date

1999-11-23

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 description 31
• 239000000203 mixture Substances 0.000 description 19
• 150000001413 amino acids Chemical class 0.000 description 10
• 239000012634 fragment Substances 0.000 description 8
• 210000000988 bone and bone Anatomy 0.000 description 6
• RRBCHMCWWOHRQL-UMXFMPSGSA-N parathyroid hormone (1-34)amide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C1=CN=CN1 RRBCHMCWWOHRQL-UMXFMPSGSA-N 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• 108020004511 Recombinant DNA Proteins 0.000 description 5
• 210000004027 cell Anatomy 0.000 description 5
• 102000053602 DNA Human genes 0.000 description 4
• 208000001132 Osteoporosis Diseases 0.000 description 4
• OXZNHYPGOAWYLT-FISSOZIDSA-N ostabolin Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)OC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C1C=NC=N1 OXZNHYPGOAWYLT-FISSOZIDSA-N 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 3
• 238000000034 method Methods 0.000 description 3
• 108020004707 nucleic acids Proteins 0.000 description 3
• 102000039446 nucleic acids Human genes 0.000 description 3
• 150000007523 nucleic acids Chemical class 0.000 description 3
• 108010067557 parathyroid hormone (1-34)amide Proteins 0.000 description 3
• 241000894006 Bacteria Species 0.000 description 2
• 230000010072 bone remodeling Effects 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 208000006386 Bone Resorption Diseases 0.000 description 1
• 108020004414 DNA Proteins 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 206010039984 Senile osteoporosis Diseases 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 230000024279 bone resorption Effects 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1